Diagnostic Medical Systems S.A. (ALDMS.PA)
EUR 0.68
(-2.57%)
EUR 0.68
(-2.57%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 18.1 Million EUR | 11.15% |
| 2022 | 16.29 Million EUR | 12.76% |
| 2021 | 14.44 Million EUR | -10.86% |
| 2020 | 16.2 Million EUR | 24.29% |
| 2019 | 13.04 Million EUR | 9.63% |
| 2018 | 11.89 Million EUR | -11.52% |
| 2017 | 13.44 Million EUR | -26.93% |
| 2016 | 18.39 Million EUR | 2.28% |
| 2015 | 17.98 Million EUR | 48.99% |
| 2014 | 12.07 Million EUR | 33.01% |
| 2013 | 9.07 Million EUR | 2.54% |
| 2012 | 8.85 Million EUR | 161.28% |
| 2011 | 3.38 Million EUR | -69.29% |
| 2010 | 11.03 Million EUR | 6.66% |
| 2009 | 10.34 Million EUR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 176 Thousand EUR | 0.0% |
| 2023 Q4 | 56 Thousand EUR | 0.0% |
| 2023 Q2 | 374 Thousand EUR | 15734.04% |
| 2023 FY | 18.1 Million EUR | 11.15% |
| 2023 Q1 | 2362.00 EUR | -99.87% |
| 2022 Q4 | 1.81 Million EUR | 0.0% |
| 2022 FY | 16.29 Million EUR | 12.76% |
| 2022 Q2 | 102 Thousand EUR | -98.26% |
| 2022 Q1 | 5.84 Million EUR | 2019.02% |
| 2021 FY | 14.44 Million EUR | -10.86% |
| 2021 Q1 | 4.06 Million EUR | 906.68% |
| 2021 Q2 | 53 Thousand EUR | -98.7% |
| 2021 Q4 | 276 Thousand EUR | 0.0% |
| 2020 Q1 | 4 Million EUR | 1416.67% |
| 2020 Q3 | 7.7 Million EUR | 4332.42% |
| 2020 Q2 | -182 Thousand EUR | -104.55% |
| 2020 Q4 | 404 Thousand EUR | -94.76% |
| 2020 FY | 16.2 Million EUR | 24.29% |
| 2019 FY | 13.04 Million EUR | 9.63% |
| 2019 Q4 | 264 Thousand EUR | -93.04% |
| 2019 Q3 | 3.79 Million EUR | 4.88% |
| 2019 Q1 | 3.61 Million EUR | -12.63% |
| 2019 Q2 | 3.61 Million EUR | 0.0% |
| 2018 Q1 | 3.53 Million EUR | -25.19% |
| 2018 FY | 11.89 Million EUR | -11.52% |
| 2018 Q4 | 4.13 Million EUR | 0.0% |
| 2018 Q3 | 4.13 Million EUR | 17.0% |
| 2018 Q2 | 3.53 Million EUR | 0.0% |
| 2017 FY | 13.44 Million EUR | -26.93% |
| 2017 Q3 | 4.72 Million EUR | 77.13% |
| 2017 Q4 | 4.72 Million EUR | 0.0% |
| 2017 Q1 | 2.67 Million EUR | -46.98% |
| 2017 Q2 | 2.67 Million EUR | 0.0% |
| 2016 FY | 18.39 Million EUR | 2.28% |
| 2016 Q3 | 5.03 Million EUR | 6.83% |
| 2016 Q4 | 5.03 Million EUR | 0.0% |
| 2016 Q1 | 4.71 Million EUR | -14.94% |
| 2016 Q2 | 4.71 Million EUR | 0.0% |
| 2015 Q2 | 3.82 Million EUR | 0.0% |
| 2015 Q4 | 5.54 Million EUR | 0.0% |
| 2015 Q3 | 5.54 Million EUR | 44.95% |
| 2015 Q1 | 3.82 Million EUR | 14.91% |
| 2015 FY | 17.98 Million EUR | 48.99% |
| 2014 Q4 | 3.32 Million EUR | 0.0% |
| 2014 FY | 12.07 Million EUR | 33.01% |
| 2014 Q3 | 3.32 Million EUR | 50.53% |
| 2014 Q1 | 2.21 Million EUR | -14.29% |
| 2014 Q2 | 2.21 Million EUR | 0.0% |
| 2013 Q2 | 2.14 Million EUR | 0.0% |
| 2013 Q1 | 2.14 Million EUR | 0.0% |
| 2013 FY | 9.07 Million EUR | 2.54% |
| 2013 Q4 | 2.57 Million EUR | 0.0% |
| 2013 Q3 | 2.57 Million EUR | 20.35% |
| 2012 FY | 8.85 Million EUR | 161.28% |
| 2011 FY | 3.38 Million EUR | -69.29% |
| 2010 FY | 11.03 Million EUR | 6.66% |
| 2009 FY | 10.34 Million EUR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Affluent Medical SA | 11.86 Million EUR | -52.604% |
| Bluelinea Société Anonyme | 11.43 Thousand EUR | -158200.551% |
| Carmat SA | 21.54 Million EUR | 15.964% |
| Euromedis Groupe | 17.6 Million EUR | -2.832% |
| Eurobio Scientific Société anonyme | 47.34 Million EUR | 61.755% |
| Ikonisys S.A. | 2.44 Million EUR | -639.236% |
| Implanet S.A. | 9.29 Million EUR | -94.898% |
| Median Technologies SA | 46.34 Million EUR | 60.925% |
| SpineGuard SA | 7.35 Million EUR | -146.195% |
| Theraclion SA | -1.08 Million EUR | 1776.069% |
| Euroapi S.A. | 398.9 Million EUR | 95.461% |
| Guerbet SA | 550.79 Million EUR | 96.712% |
| Ion Beam Applications SA | 128.02 Million EUR | 85.856% |
| Koninklijke Philips N.V. | 5.84 Billion EUR | 99.69% |
| Sequana Medical NV | 30.03 Million EUR | 39.719% |